This business-led collaborative research and development competition will fund new engineering-biology products, processes and services and de-risk technologies with strong market potential. Projects may address health, agriculture and food, chemicals and materials, low-carbon fuels, waste and environment, or cross-cutting technology and service development. The central innovation must purposefully engineer biological systems and may involve biosensors, biomanufacturing, synthetic-biology platforms, gene editing, AI or computational biology. Projects must have total eligible costs of £750,000 to £2.5 million, last 12 to 36 months and begin no earlier than 1 April 2027. The open competition closes on 3 November 2026 at 11:00am UK time.
We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.